Tag Archives: Plague
Potential protection against plague discovered
A research team led by Dr. Stephen Smiley at the Trudeau Institute in New York has discovered a new protective property of an immune system T cell that may protect the human body against plague. Read More
Research continues for plague vaccine
Research is continuing on the development of a vaccine that will protect the public against weaponized forms of the plague. Read More
IntegenX awarded contract for rapid detection of engineered bacteria
IntegenX, Inc., has been awarded the first phase of a $2.8 million contract to develop an integrated sample-to-sequence system that would help in the rapid detection and identification of genetically engineered bacteria and viruses. Read More
Y. pestis revealed to be source of the Black Death
Anthropologists say they may have discovered the secret behind the Black Death plague that annihilated one-third of Europe during the Middle Ages.
Read More
Plague reported in Peru
The World Health Organization has confirmed a total of 17 cases of plague in Ascope province of the Department La Libertad region in Peru as of the end of July. Read More
Bubonic plague vaccine trials set
Clinical trials are beginning for a bubonic plague vaccine, which officials say is a viable bioterror threat, at 10 sites nationwide. Read More
Mysterious plague outbreak among Syrian army
An outbreak of plague, which is considerd a potential bioweapon, among the Syrian military may be raising more questions than answers. Read More
New test developed for plague
Scientists working for the U.S. Army’s Walter Reed Institute of Research have developed a new test for the presence of Y. pestis, the causative agent of bubonic and pneumonic plague. Read More
iBioLaunch to be used to develop anthrax and plague vaccine
iBio, Inc. has confirmed that its has granted rights for its iBioLaunch propietary technology to be used in support of a government-funded project developing a single vaccine to protect against both anthrax and plague. Read More
FDA aids Advanced Life Sciences Holdings in approval assessment for anthrax drug
The FDA has given guidance to Advanced Life Sciences Holdings, Inc., on the clinical program required to assess the approvability of Restanza, which has been developed to fight anthrax, plague and tularemia, among others. Read More
Posted in Medical Countermeasures, News
Tagged anthrax, immunization, Plague, tularemia
Comments Off
